Literature DB >> 28505266

Guidance for Modifying the Definition of Diseases: A Checklist.

Jenny Doust1, Per O Vandvik2, Amir Qaseem3, Reem A Mustafa4, Andrea R Horvath5, Allen Frances6, Lubna Al-Ansary7, Patrick Bossuyt8, Robyn L Ward9, Ina Kopp10, Laragh Gollogly11, Holger Schunemann12, Paul Glasziou1.   

Abstract

Importance: No guidelines exist currently for guideline panels and others considering changes to disease definitions. Panels frequently widen disease definitions, increasing the proportion of the population labeled as unwell and potentially causing harm to patients. We set out to develop a checklist of issues, with guidance, for panels to consider prior to modifying a disease definition. Observations: We assembled a multidisciplinary, multicontinent working group of 13 members, including members from the Guidelines International Network, Grading of Recommendations Assessment, Development and Evaluation working group, and the World Health Organisation. We used a 5-step process to develop the checklist: (1) a literature review of issues, (2) a draft outline document, (3) a Delphi process of feedback on the list of issues, (4) a 1-day face-to-face meeting, and (5) further refinement of the checklist. The literature review identified 12 potential issues. From these, the group developed an 8-item checklist that consisted of definition changes, number of people affected, trigger, prognostic ability, disease definition precision and accuracy, potential benefits, potential harms, and the balance between potential harms and benefits. The checklist is accompanied by an explanation of each item and the types of evidence to assess each one. We used a panel's recent consideration of a proposed change in the definition of gestational diabetes mellitus (GDM) to illustrate use of the checklist. Conclusions and Relevance: We propose that the checklist be piloted and validated by groups developing new guidelines. We anticipate that the use of the checklist will be a first step to guidance and better documentation of definition changes prior to introducing modified disease definitions.

Entities:  

Mesh:

Year:  2017        PMID: 28505266     DOI: 10.1001/jamainternmed.2017.1302

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  20 in total

1.  Media Coverage of the Benefits and Harms of the 2017 Expanded Definition of High Blood Pressure.

Authors:  Raymond Noel Moynihan; Justin Clark; Loai Albarqouni
Journal:  JAMA Intern Med       Date:  2019-02-01       Impact factor: 21.873

2.  Choice of Reference Creatinine for Post-Traumatic Acute Kidney Injury Diagnosis.

Authors:  Gabrielle E Hatton; Reginald E Du; Claudia Pedroza; Shuyan Wei; John A Harvin; Kevin W Finkel; Charles E Wade; Lillian S Kao
Journal:  J Am Coll Surg       Date:  2019-09-20       Impact factor: 6.113

Review 3.  Overdiagnosis in primary care: framing the problem and finding solutions.

Authors:  Minal S Kale; Deborah Korenstein
Journal:  BMJ       Date:  2018-08-14

Review 4.  Public health implications of overscreening for carotid artery stenosis, prediabetes, and thyroid cancer.

Authors:  Bich-May Nguyen; Kenneth W Lin; Ranit Mishori
Journal:  Public Health Rev       Date:  2018-07-02

Review 5.  Pregnant pause: should we screen for sleep disordered breathing in pregnancy?

Authors:  Alex Perkins; Alys Einion
Journal:  Breathe (Sheff)       Date:  2019-03

6.  Population-wide analysis of differences in disease progression patterns in men and women.

Authors:  David Westergaard; Pope Moseley; Freja Karuna Hemmingsen Sørup; Pierre Baldi; Søren Brunak
Journal:  Nat Commun       Date:  2019-02-08       Impact factor: 14.919

7.  Public, health professional and legislator perspectives on the concept of psychiatric disease: a population-based survey.

Authors:  Kari A O Tikkinen; Jarno Rutanen; Allen Frances; Brea L Perry; Brittany B Dennis; Arnav Agarwal; Amna Maqbool; Shanil Ebrahim; Janne S Leinonen; Teppo L N Järvinen; Gordon H Guyatt
Journal:  BMJ Open       Date:  2019-06-04       Impact factor: 2.692

Review 8.  Why primary obesity is a disease?

Authors:  Antonino De Lorenzo; Santo Gratteri; Paola Gualtieri; Andrea Cammarano; Pierfrancesco Bertucci; Laura Di Renzo
Journal:  J Transl Med       Date:  2019-05-22       Impact factor: 5.531

9.  Albuminuria: population epidemiology and concordance in Australian children aged 11-12 years and their parents.

Authors:  Nicholas G Larkins; Siah Kim; John B Carlin; Anneke C Grobler; David P Burgner; Katherine Lange; Jonathan C Craig; Melissa Wake
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

10.  Estimated impact of introduction of new diagnostic criteria for gestational diabetes mellitus.

Authors:  Leon de Wit; Anna B Zijlmans; Doortje Rademaker; Christiana A Naaktgeboren; J Hans DeVries; Arie Franx; Rebecca C Painter; Bas B van Rijn
Journal:  World J Diabetes       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.